Fractional Flow Reserve (FFR)

Similar documents
CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

Noninvasive Fractional Flow Reserve from Coronary CT Angiography

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study

Fractional Flow Reserve: Review of the latest data

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls

New Insight about FFR and IVUS MLA

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Benefit of Performing PCI Based on FFR

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

Coronary artery disease (CAD): Fractional Flow Reserve (FFR) for Pilots Risk Assessment. B. Haaff, R. Quast

Coronary Physiology and FFR. David H. Sibley MD FACC, FSCAI, FACP

FFR in Multivessel Disease

Optimal Method for Stenosis Assessment with CT

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Fractional Flow Reserve. A physiological approach to guide complex interventions

CLINICAL CONSEQUENCES OF THE

FFR Incorporating & Expanding it s use in Clinical Practice

Between Coronary Angiography and Fractional Flow Reserve

Dave Kettles, St Dominics Hospital East London.

Focus on Acute Coronary Syndromes

FFR? FFR-CT? Ischaemia testing?

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Coronary stenting: the appropriate use of FFR

CARDIOLOGY GRAND ROUNDS

FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!

CASE from South Korea

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Debate Should we use FFR? I will say NO.

FFR-CT Not Ready for Primetime

Physiologic Assessment by Cardiac CT

Management of stable CAD FFR guided therapy: the new gold standard

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Computational Fluid Dynamics Applied to Cardiac Computed Tomography for Noninvasive Quantification of Fractional Flow Reserve Scientific Basis

Diffuse Disease and Serial Stenoses

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

Cost-Effectiveness of Fractional Flow Reserve

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Current and Future Imaging Trends in Risk Stratification for CAD

CT Determination of Fractional Flow Reserve in Coronary Lesions

FRACTIONAL FLOW RESERVE: CONCEPT, EXPERIMENTAL BASIS, CUT-OFF VALUES

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Relations of Interest

Malaysian Healthy Ageing Society

Diffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

Fractional Flow Reserve: The Past, Present and Future

Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

FFR in unstable angina and after MI F

FFR in Left Main Disease

Pamela S. Douglas, Gianluca Pontone, Mark A. Hlatky, Manesh R. Patel, Campbell Rogers, Bernard De Bruyne. On behalf of the PLATFORM Investigators

Pressure Wire Study. Fractional Flow Reserve (FFR) Nishat Jahagirdar Principal Clinical Cardiac Physiologist Kings College Hospital

SPECT or PET for Cardiovascular Screening in High-Risk Patients

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Fractional Flow Reserve and the Results of the FAME Study

Interventional Cardiology

FFR Fundamentals and Measurements

FFR and intravascular imaging, which of which?

Introducing. Integrated FFR Platform

Cardiac CT Angiography

Is computed tomography angiography really useful in. of coronary artery disease?

Patient referral for elective coronary angiography: challenging the current strategy

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

Intervention: How and to which extent is technology helping us?

The Future of Coronary Physiology

Fractional Flow Reserve and the 1 Year Results of the FAME Study

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Coronary Physiology the current state of play

Physiology (FFR & IFR) is Essential in Daily Pratice. Martine Gilard Brest University - France

Kavitha Yaddanapudi Stony brook University New York

Anatomy is Destiny, But Physiology is Here Today

PressureWire Aeris with Agile Tip Technology. Wireless FFR Functionality and Handles like a Workhorse PCI Guidewire 1

MEDICAL UNIVERSITY of SOUTH CAROLINA

FFR: Tips and Tricks. A/Prof (Adj) Yeo Khung Keong, MBBS, FAMS, FACC, FSCAI National Heart Centre Singapore

Coronary CT Angiography derived Fractional Flow Reserve 1

Coronary Computed Tomography Angiography With Selective Noninvasive Fractional Flow Reserve

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Case report. Resistance in the cath lab : the utility of hyperemic stenosis resistance in the functional assessment of coronary artery disease

Know Your Study Enrolling Studies List

3 Year Clinical Outcome and Cost-Effectiveness of FFR- Guided PCI in Stable Patients with Coronary Artery Disease: FAME 2 Trial

The invisible becomes quantifiable in coronary computed tomography angiography exams with CT-FFR

Do stents deserve the bad press? Mark A. Tulli MD, FACC

Stable Angina: Indication for revascularization and best medical therapy

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

CT-based myocardial ischemia evaluation: quantitative angiography, myocardial perfusion, and CT-FFR

Coronary Computed Tomography Angiography With Selective Noninvasive Fractional Flow Reserve

Disclosure Information

Fractional Flow Reserve (FFR) estimation GRAIDIS CHRISTOS. EUROMEDICA-KYΑNOUS STAVROS Interventional Cardiologist, FSCAI

IVUS vs FFR Debate: IVUS-Guided PCI

Cardiac CT: Your chest pain patient CAN be discharged from the Emergency Department

Transcription:

Non-invasive FFR using coronary CT angiography and computational fluid dyn amics predicts the hemodynamic signifi cance of coronary lesions First in man experience with CT-Flow Andrejs Erglis, Sanda Jegere, Zanda Runkule, Ligita Zvaigzne, Dace Sondore, Indulis Kumsars, Inga Narbute, Iveta Mintale, Andis Dombrovskis, Gustavs Latkovskis Pauls Stradins Clinical University Hospital Riga, LATVIA

Disclosures Study supported by HeartFlow, Inc., Redwood City, CA, USA CT-FLOW analysis is an investigational technology and was performed by HeartFlow, Inc. Investigators have no financial interest in HeartFlow, Inc.

Fractional Flow Reserve (FFR) Fractional flow reserve (FFR) is an index that determines the hemodynamic significance of coronary lesions; the ratio of maximal myocardial blood flow in the stenotic territory (Qs) to normal maximal myocardial blood flow (Qn) during hyperemia Q stenosis (P d -P v )/R s P d FFR = = = Q normal (P a -P v )/R n P a Q s myocardial blood flow in the stenotic territory Q n normal myocardial blood flow P a mean aortic pressure Aorta P d mean distal coronary pressure Max. hyperemia P v mean central venous pressure R s myocardial resistance in the stenotic territory R n myocardial resistance in the normal territory P a P a Coronary artery P d=a P d Myocardium Normal perfusion pressure P v P v Veins Q normal Q stenosis Bruyne BD, Sarma J. Heart 2008;94:949-959 Stenotic perfusion pressure

Ischemic Value of FFR FFR during coronary angiography with adenosine induced hyperemia is the reference standard for determining the hemodynamic significance of coronary artery lesions Normal value of FFR is 1.0. No ischemia Grey zone Ischemia FFR 1.00 0.80 0.75 0.00 Pijls, De Bruyne et al, NEJM 1996

FFR-Guided PCI FFR-guided coronary revascularization (percutaneous coronary intervention, PCI) improves the long term clinical outcome of patients with coronary artery disease (CAD) Survival free from MACE Days since randomization DEFER: Pijls JACC 2007;49:2105 FAME: Pijls JACC 2010;56:177

Coronary CT angiography Coronary CT angiography (CCTA) is a non-invasive method in evaluation of coronary artery disease with a high sensitivity for detection of disease and a high negative predictive value for exclusion of obstructive lesions Sensitivity Specificity PPV NPV ACCURACY 94 83 48 99 N=230, Stable Chest Pain; No known CAD; No exclusion (CACS, HR, BMI); CAD prevalence 13% CorE64 85 90 91 83 N=291, Stable Chest Pain; No known and Known CAD; Exclusion CACS>600; CAD prevalence 56% Meijboom 99 64 85 97 N=360, Acute and Stable Chest Pain; No known CAD; CAD prevalence 68% Budoff MJ et al, JACC 2008;52:1724-1732; Miller JM et al, NEJM 2008;359:2324-2336 Meijboom WB et al, JACC 2008; 52:2135-2144

CCTA vs. FFR However, CCTA has a high false positive rate when compared to angiography/ffr and cannot define the hemodynamic significance of coronary lesions FFR 75% false positives 75% of lesions with > 50% stenosis by CCTA are false positives Meijboom WB et al, JACC 2008;52:636-643

Computational fluid dynamics Computational fluid dynamics (CFD), quantifies fluid pressure and velocity, based on physical laws of mass conservation and momentum balance CFD is widely used in the aerospace and automotive industries for design and testing CFD techniques have now been applied to analyze problems of human blood flow Images courtesy of Prof. Charbel Farhat, Dept. of Aeronautics & Astronautics, Stanford University

CFD application to coronary arteries CT-FLOW CCTA 3D Model Supercomputer Simulated Hyperemic Blood Flow & Pressure Equations of Blood Flow Physiologic conditions Aortic pressure Coronary flow at rest Effect of hyperemia on microcirculation CT-FLOW is an investigational device

Computed blood flow & pressure Pressure Velocity Rest Hyperemia

Computed FFR Mean coronary pressure is divided by aortic pressure in hyperemic state to compute FFR Simulated mean pressure with hyperemia FFR = Coronary / aortic pressure with hyperemia

Methods to correlate computed and measured FFR 0.86 3D model with computed FFR Model is rotated to same projection as angio with FFR measurement

Study Objective To evaluate the diagnostic performance of CT-FLOW in determining the hemodynamic significance of coronary artery lesions using FFR measured during coronary angiography as the reference standard

Methods 20 patients with known or suspected CAD underwent both coronary CT and angiography with FFR measurement Significant coronary stenosis was defined as 50% luminal diameter by coronary CT Hemodynamically significant stenosis at cath was defined at threshold values of 0.75 and 0.80 Computed FFR was determined in a blinded fashion by computational analysis based on the coronary CT scan

Patient and lesion characteristics Patients N=20 Age, mean ± SD 62.4 ± 8.3 years Male, n, % 11 55 % Diabetes, n, % 3 15 % Hypertension, n, % 17 85 % Hyperlipidemia, n, % 20 100 % Smoking, n, % 10 50 % Previous MI, n, % 10 50 % Previous PCI, n, % 8 40 %

Case Example #1

Case Example #1 CCTA: 3D

Case Example #1 CCTA: 2D

Case Example #1 CCTA: 2D

Case Example #1 Coronary Angiography

Coronary CT image CT-FLOW model with simulated hyperemia P Coronary P Aorta 0.95 0.93 Measured FFR Computed FFR Model rotated to plane of angio

Case Example #2 Coronary Angiography

Case Example #2 Coronary Angiography

Case Example #2 CCTA: 2D

Coronary CT image CT-FLOW model with simulated hyperemia P Coronary P Aorta Measured FFR Computed FFR Model rotated to plane of angio

Case Example #2 PCI

Diagnostic Correlation CT-FLOW vs. FFR per lesion analysis (n=33) 1.0.9 False positives.8 FFR Measured FFR.7.6.5.4.3.2 r=0.743 p<0.001 False negatives.1 0.0 FFR: 0.84 + 0.13 CT-FLOW: 0.81 + 0.11 0.0.1.2.3.4.5.6 CT-FLOW Computed FFR.7.8.9 1.0

Diagnostic Performance Measures for determining the hemodynamic significance of lesions per patient analysis (n=20) True Positives False Positives True Negatives False negatives FFR < 0.80 FFR < 0.75 Coronary CT CT-FLOW Coronary CT CT-FLOW 8 10 5 6 6 2 9 3 5 8 5 11 1 0 1 0 CT-FLOW: 3-fold reduction in false positives, zero false negatives

Diagnostic Performance Per-patient FFR 0.80 threshold* *as per FAME study

Diagnostic Performance Per-patient FFR <0.75 threshold* *As per DEFER study

Summary of Results Addition of CFD analysis to coronary CT (CT- FLOW) markedly improved the diagnostic accuracy for determination of hemodynamic significance of coronary artery disease Diagnostic accuracy improved from 65% to 90%» 0.80 FFR threshold Diagnostic accuracy improved from 50% to 85%» 0.75 FFR threshold

Limitations Single center, first-in-man experience with new technology Small patient sample size

Conclusions CFD analysis of coronary CT imaging data can accurately assess the hemodynamic significance of coronary artery lesions CT-FLOW provides a non-invasive anatomic and functional assessment of CAD which may improve the selection of patients for coronary angiography and intervention Prospective, multicenter studies in larger patient cohorts are needed to validate these early findings

Thank you!